Pembrolizumab in Cervix Cancer

37-year-old with a history of advanced, recurrent metastatic cervical cancer is starting chemotherapy with Carboplatin, Paclitaxel, and Bevacizumab. You are awaiting PDL testing on the tumor. What test will make this patient eligible for the addition of pembrolizumab?

Correct Answer: Combined Positive Score (CPS) greater than or equal to 1

Log in to view the explanation